G

GE Healthcare

Imaging, monitoring, and healthcare IT solutions

Global Product Manager - Cardiology Solutions Devices

Full-TimeUpdated on 10/23/2026
$130.4k - $195.6k/yr+ Performance-based bonus + Long-term incentives
Senior, Expert
Bachelor's, Master's, MBA
Chicago, IL, USA+1 moreMore locations: Waukesha, WI, USA
In PersonTravel 10–20% domestically and internationally.
ProductProduct Management
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in marketing, business administration, engineering, or a related field is required.
  • At least 8 years of work experience in product management, product marketing, product development, technology, clinical work, or a related field is required.
  • At least 5 years of work experience in product management is required.
  • At least 3 years of experience translating customer and market insights into value propositions, product requirements, business cases, roadmaps, and lifecycle plans is required.
  • Healthcare product, industry, or technical acumen is required.
  • Ability to work effectively within a global, matrixed environment is required.
  • Experience working within a quality system and familiarity with regulatory and quality processes are required.
  • Strong interpersonal skills, clear articulation, and business decision-making ability are required.
  • Ability to analyze and resolve problems is required.
  • Ability to document, plan, market, and execute programs is required.
  • Strong analytical and process skills and demonstrated project management skills are required.
  • Ability to travel 10–20% of the time, domestically and internationally, is required.
  • Legal authorization to work in the United States is required; employment visa sponsorship is not available.
  • Ability to articulate complex clinical and technical ideas clearly, concisely, and compellingly is required.
Responsibilities
  • Drive the product roadmap for resting, stress, and Holter ECG products and execute the AI algorithm strategy.
  • Provide product leadership by owning execution of global product strategy, including service solutions and commercial offerings.
  • Ensure customer focus in product line development plans and value propositions by establishing customer relationships and reflecting the voice of the customer in work efforts.
  • Develop and communicate creative solutions to customer problems.
  • Own product definitions, target customer segments, use cases, user requirements, value propositions, and business cases for development and lifecycle investments.
  • Support the vision and strategic execution for ECG devices and connectivity to the ecosystem.
  • Collaborate with other product managers to define requirements for integrating partner-driven solutions into the larger ECG ecosystem.
  • Use sound judgment to prioritize needs, manage trade-offs, maintain accountability, and communicate clinical, technical, and commercial concepts in a global matrix environment.
  • Develop the product roadmap using knowledge of cardiology and industry trends, competition, and markets.
  • Lead cross-organizational integration of ECG products into GE HealthCare systems and platforms.
  • Provide input on and implement new commercial models, including software-as-a-service and subscription offerings.
  • Partner with Engineering, Clinical, Design, Quality, Regulatory, Service, Product Marketing, Commercial, and regional teams to deliver product development commitments predictably and quickly.
  • Represent Cardiology Solutions devices in business and customer meetings, leadership discussions, advisory boards, industry forums, and partner engagements.
  • Own product financial performance, including budgeting, profitability, growth rates, pricing, gaps to target, and pipeline health.
  • Manage the product lifecycle from detailed development planning through product termination.
  • Define product models and structures and identify offering items and structures.
  • Develop and motivate others on strategies and operating mechanisms to deliver business results.
Desired Qualifications
  • An MBA or master's degree in marketing, engineering, business administration, healthcare, or a related field is desired.
  • Demonstrated knowledge of clinical cardiovascular, ECG, cardiac interventional, or related cardiology expertise is desired.
  • Demonstrated oral and written communication skills, including engaging customers and influencing executive and cross-functional audiences, are desired.
  • Commercial expertise selling cloud-based systems, software, and service products to business or direct customers is desired.
  • An innovative, customer-centric mindset and strong problem-solving, negotiation, and organizational skills are desired.

About the company

GE Healthcare Systems provides medical technologies and digital infrastructure to improve diagnosis, treatment, and monitoring of patients. Its products include imaging systems, mobile diagnostic devices, patient monitoring tools, and healthcare IT software that work together as hardware, software, and services to support hospitals, clinics, and researchers. The company differentiates itself with a large, integrated ecosystem, strong focus on AI analytics, and a global service network backed by substantial R&D investment. Its goal is to improve patient outcomes and the efficiency of healthcare delivery by enabling accurate diagnoses, effective treatments, and scaled operations.

Company Size

1-10

Company Stage

IPO

Headquarters

Chicago, Illinois

Founded

1892

Get referred to GE Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 orders rose 11% and backlog reached a record $23.9 billion.
  • CareIntellect for Operations launched September 2026 with Duke Health and Queen's Health Systems.
  • CE mark and FDA progress for Photonova Spectra expand 2026-2027 commercial momentum.

What critics are saying

  • FDA logged multiple 2026 Class 2 recalls, including AW Server and telemetry systems.
  • Patient Care Solutions remained weak in Q2 2026; management is reviewing a sale.
  • SOFIE closes only after 2027 regulatory approvals; PET supply integration can slip badly.

What makes GE Healthcare unique

  • GE HealthCare combines imaging hardware, radiopharmaceuticals, and workflow software across hospitals.
  • Photonova Spectra and Vivid 2026 show premium innovation plus AI-enabled clinical automation.
  • SOFIE's 21 cyclotrons extend GE HealthCare into radiotracer manufacturing, not just scanners.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Tuition Reimbursement
  • Relocation Assistance

Company News

Yahoo Finance
Oct 23rd, 2026
Cash-rich stocks: Clean Harbors worth watching, UPS and GE HealthCare best avoided

StockStory has named one cash-generating stock worth a closer look and two it would avoid, arguing that strong cash flow does not always mean strong returns. Clean Harbors (NYSE:CLH) is the pick. Its revenue grew 13.5% a year over five years, and earnings per share rose 21.6% a year, helped by share buybacks. Its free cash flow margin is 8.8%, up 5.9 percentage points over five years. The shares trade at $320.91, or 30.7x forward earnings. StockStory would steer clear of United Parcel Service (NYSE:UPS) and GE HealthCare (NASDAQ:GEHC). UPS sales were flat over five years while earnings per share fell 8.4% a year. GE HealthCare faces projected sales growth of 4.4% and a 1.7-point drop in adjusted operating margin.

Associated Press
Oct 20th, 2026
GE HealthCare launches five-institution global trial of StarGuide GX theranostics SPECT/CT system

GE HealthCare has launched a clinical evaluation program for StarGuide GX, its next-generation digital 4D SPECT/CT system. Five institutions across three continents will take part. They are Hadassah Medical Center and Rambam Health Care Campus in Israel, Mayo Clinic in the US, Oncopole Claudius Regaud in France, and Peking University First Hospital in China. Each will assess image quality, quantitative performance, dynamic imaging, and workflow, and give feedback to guide the system's development. StarGuide GX uses dual-sided cadmium zinc telluride detectors and a dual-collimator design meant to remove manual collimator changes. It also uses NVIDIA RTX accelerated computing for image reconstruction. The system received CE Mark in November 2025 and is on sale in select EU states. Its US Food and Drug Administration 510(k) clearance is pending.

Yahoo Finance
Oct 19th, 2026
GE HealthCare launches LOGIQ Focus ultrasound with AI tools, 26% faster scans

GE HealthCare has launched LOGIQ Focus, a new general imaging ultrasound system in its LOGIQ family. The company announced the product in Chicago on October 19, 2026. The system runs on cSound Architecture and pairs high-definition imaging with AI-enabled tools. One of them, Auto Preset Assistant, detects the anatomy being scanned and activates the matching preset, saving up to five clicks per exam. In a third-party study, 90% of participants rated its image quality as excellent. The system was 26% faster than the predicate system. LOGIQ Focus is 510(k) cleared and CE Marked. GE HealthCare expects it and several other new products to add 1% to 2% to revenue growth, following more than $5 billion in innovation investment since 2023.

Business Wire
Oct 5th, 2026
GE HealthCare to acquire SOFIE Biosciences for $945M to expand US radiopharmaceutical supply

GE HealthCare has agreed to acquire SOFIE Biosciences, a US-based contract manufacturer of PET radiopharmaceuticals, for $945 million in cash. The deal with seller Trilantic North America is expected to close in the first half of 2027, subject to regulatory approvals. SOFIE Biosciences operates 15 contract manufacturing sites with 21 cyclotrons across the US, plus a theranostics-focused development and manufacturing facility. The acquisition establishes GE HealthCare's presence in the time-critical "final mile" of US PET radiopharmaceutical supply. The PET radiopharmaceutical market is expanding rapidly with approximately 20 PET radiotracers and over 30 radiotherapeutics currently under development. SOFIE Biosciences' portfolio includes a Phase III FAPI asset for which GE HealthCare already holds non-US rights. GE HealthCare estimates the transaction will be accretive to revenue growth, earnings margin, and earnings per share in the first full year of ownership.

PR Newswire
Sep 30th, 2026
AsiaMedic first in ASEAN to deploy GE HealthCare's MR31 deep learning MRI platform

AsiaMedic has become the first site in ASEAN to implement MR31, GE HealthCare's latest generation MRI platform featuring deep learning technology. The Singapore-based imaging centre is among the earliest adopters in Asia Pacific. MR31 incorporates deep learning technologies that reduce scan times and enable detailed examinations across neurological, musculoskeletal and nerve imaging. Sonic DL for 3D delivers up to 12 times scan acceleration, reducing examination times across brain, spine, orthopaedic and body scans. The platform also supports high-quality prostate MRI imaging. AIR Recon DL Phase Correction provides improved visualisation of clinically significant lesions, whilst high-resolution T2-weighted imaging aids lesion localisation for prostate fusion biopsy planning. Shorter scan times mean reduced patient time in scanners and may help decrease repeat examinations caused by movement.